| MeSH term | MeSH ID | Detail |
|---|---|---|
| Pancreatic Neoplasms | D010190 | 77 associated lipids |
| Body Weight | D001835 | 333 associated lipids |
| Arteriosclerosis | D001161 | 86 associated lipids |
Total
3
Norethindrone
Norethindrone is a lipid of Sterol Lipids (ST) class. Norethindrone is associated with abnormalities such as Endometriosis, site unspecified, Wiskott-Aldrich Syndrome and Estrogenic effect. The involved functions are known as Hemorrhage, Phosphorylation, Apoptosis, DNA Repair and Cell Cycle. Norethindrone often locates in Blood, Back, Body tissue, Nucleolar and Human tissue. The associated genes with Norethindrone are MMP gene, NR3C1 gene and Genes, Reporter. The related lipids are Steroids, 4,17 beta-dihydroxy-4-androstene-3-one, 4-estren-3,17-diol and Estranes.
Cross Reference
Introduction
To understand associated biological information of Norethindrone, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Norethindrone?
Norethindrone is suspected in Endometriosis, site unspecified, Estrogenic effect and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Norethindrone
PubChem Associated disorders and diseases
What pathways are associated with Norethindrone
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Norethindrone?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Norethindrone?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Norethindrone?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Norethindrone?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Norethindrone?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Norethindrone
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| De Aguilar MA et al. | Current status of injectable hormonal contraception, with special reference to the monthly method. | 1997 | Adv Contracept | pmid:9404550 |
| Phase II clinical study of implanted norethindrone pellets for longterm contraception in women. Program for Applied Research on Fertility Regulation. | 1985 | Adv Contracept | pmid:3842220 | |
| Singh M et al. | Contraceptive efficacy of norethindrone encapsulated in injectable biodegradable poly-dl-lactide-co-glycolide microspheres (NET-90): phase III clinical study. | 1997 | Adv Contracept | pmid:9181181 |
| Cong H and Beck LR | Preparation and pharmacokinetic evaluation of a modified long-acting injectable norethisterone microsphere. | 1991 Jun-Sep | Adv Contracept | pmid:1950722 |
| Spellacy WN et al. | Two-year carbohydrate metabolism studies in women using a norethindrone or levonorgestrel triphasic oral contraceptive. | 1990 | Adv Contracept | pmid:2123370 |
| de Cetina TC et al. | A comparative clinical trial of Norinyl 1 + 35 versus Norinyl 1 + 50 in Merida, Yucatan, Mexico. | 1990 | Adv Contracept | pmid:2206018 |
| Sapire KE | A study of bleeding patterns with two injectable contraceptives given postpartum and the effect of two non-hormonal treatments. | 1991 | Adv Contracept | pmid:1837974 |
| Zanartu J | A new approach to fertility control: long-acting injectable progesterones. | 1968 | Adv Fertil Control | pmid:12255478 |
| Norethin: lower cost can improve OC compliance. | 1997 | Adv Nurse Pract | pmid:9460009 | |
| Laufe LE et al. | Volume and copper concentration of menstrual discharge from women employing copper-7 and other types of contraceptives. | 1974 | Adv Plan Parent | pmid:4468904 |
| Vecchio TJ | Long-acting injectable contraceptives. | 1976 | Adv Steroid Biochem Pharmacol | pmid:779431 |
| Johansen OE and Qvigstad E | Rationale for low-dose systemic hormone replacement therapy and review of estradiol 0.5 mg/NETA 0.1 mg. | 2008 | Adv Ther | pmid:18568306 |
| Prentice RL and Thomas DB | On the epidemiology of oral contraceptives and disease. | 1987 | Adv. Cancer Res. | pmid:3314396 |
| Rutter T | The future for injectable contraceptives. | 1993 | Afr Health | pmid:12344840 |
| Briggs MH and Briggs M | Preliminary studies on metabolic effects of a continuous-dose, progestogen-only, oral contraceptive. | 1972 | Afr J Med Sci | pmid:5028467 |
| Sule S and Shittu O | Weight changes in clients on hormonal contraceptives in Zaria, Nigeria. | 2005 | Afr J Reprod Health | pmid:16485589 |
| Beksinska ME and Rees HV | Vaginal discharge: a perceived side effect and minor reason for discontinuation in hormonal injectable users in South Africa. | 2001 | Afr J Reprod Health | pmid:12471932 |
| Opare-Addo HS et al. | A study of the use of Primolut N tablet as a contraceptive in the Kumasi metropolis of Ghana. | 2011 | Afr J Reprod Health | pmid:21987939 |
| Abdul-Hadi RA et al. | The effectiveness of community based distribution of injectable contraceptives using community health extension workers in Gombe State, Northern Nigeria. | 2013 | Afr J Reprod Health | pmid:24069754 |
| Werner M and Werner D | Metabolism and pharmacokinetics of aminophenazone in man of different age and under various pathological conditions. | 1982 | Agents Actions Suppl. | pmid:6956227 |
| Zuin A et al. | Living on the edge: stress and activation of stress responses promote lifespan extension. | 2010 | Aging (Albany NY) | pmid:20453258 |
| Aweeka FT et al. | The impact of sex and contraceptive therapy on the plasma and intracellular pharmacokinetics of zidovudine. | 2006 | AIDS | pmid:16954724 |
| Morrison CS et al. | Hormonal contraception and the risk of HIV acquisition among women in South Africa. | 2012 | AIDS | pmid:22156973 |
| Recruitment underway for oral contraceptive trial. | 1998 | AIDS Patient Care STDS | pmid:11361978 | |
| Kancheva Landolt NT et al. | Contraception in HIV-positive female adolescents. | 2011 | AIDS Res Ther | pmid:21631913 |
| Sassi AB et al. | Preformulation and stability in biological fluids of the retrocyclin RC-101, a potential anti-HIV topical microbicide. | 2011 | AIDS Res Ther | pmid:21801426 |
| Karim M and El-mahgoub S | Injectable steroids as a method of contraception. | 1970 | Ain Shams Med J | pmid:12313080 |
| Yassin S et al. | Ovarian morphological changes with injectable contraceptives and their relation to cycle control. | 1971 | Ain Shams Med J | pmid:12256861 |
| Alekseeva ML et al. | [Pulsed secretion of gonadotropins in polycystic ovary syndrome]. | 1991 | Akush Ginekol (Mosk) | pmid:1746702 |
| Marchenko LA | [Effectiveness of treatment of patients with pre-menopausal dysfunctional uterine hemorrhages with norcolut]. | 1985 | Akush Ginekol (Mosk) | pmid:2933973 |
| LandekhovskiÄ IuD | [Hormonal therapy and uterine steroid receptors in myoma]. | 1986 | Akush Ginekol (Mosk) | pmid:2939738 |
| Marchenko LA et al. | [Effects of substitution hormonal therapy on the hemostasis system in the pathologic climacteric]. | 1986 | Akush Ginekol (Mosk) | pmid:3017141 |
| LandekhovskiÄ IuD and ZaÄdieva IaZ | [Characteristics of the volemic shifts during the use of norethisterone in the process of the dispensary management of uterine myoma]. | 1980 | Akush Ginekol (Mosk) | pmid:7377468 |
| Kondrikov NI and Trutko NS | [Morphological and biochemical characteristics of the endometrium of women taking small doses of norethisterone]. | 1980 | Akush Ginekol (Mosk) | pmid:7377479 |
| Zheleznov BI and Beliaeva LA | [Changes in the endometrial proliferative processes under the influence of progesterone and norethisterone in an organ culture]. | 1980 | Akush Ginekol (Mosk) | pmid:7377496 |
| Sadykova MSh et al. | [Characteristics of thyroid function in goiter patients taking oral contraceptives]. | 1986 | Akush Ginekol (Mosk) | pmid:2429571 |
| Vikhliaeva EM | [New achievements in gynecology]. | 1974 | Akush Ginekol (Mosk) | pmid:4280879 |
| Beliaeva LA et al. | [Ultrastructure of cells of hyperplastic endometrium after the direct impact of gestagens]. | 1984 | Akush Ginekol (Mosk) | pmid:6524620 |
| LandekhovskiÄ IuD and Strizhakov AN | [Conservative myomectomy in the complex treatment of patients with uterine myoma]. | 1989 | Akush Ginekol (Mosk) | pmid:2694848 |
| ZaÄdieva IaZ et al. | [Effect of norethisterone acetate on water-electrolyte balance in patients with uterine myoma]. | 1979 | Akush Ginekol (Mosk) | pmid:474900 |
| Dobrotina AF and Lekomtsev SP | [Hypophyseal gonadotropic and prolactin-secreting functions in dysfunctional uterine hemorrhages depending on the method of hemostatic therapy and age]. | 1981 | Akush Ginekol (Mosk) | pmid:6171171 |
| Zheleznov BI and Beliaeva LA | [Effect of progesterone and norethisterone on the DNA content in organ cultures of hyperplastically altered endometrium]. | 1981 | Akush Ginekol (Mosk) | pmid:7246930 |
| Makatsariia AD et al. | [State of the hemostatic system in genital endometriosis patients taking large doses of gestagens]. | 1981 | Akush Ginekol (Mosk) | pmid:7246933 |
| Prilepskaia VN et al. | [Treatment effectiveness in dysfunctional uterine hemorrhages using the gestagen, Norcolut]. | 1979 | Akush Ginekol (Mosk) | pmid:507332 |
| Alipov VI and Korkhov VV | [Prolonged-action contraceptives]. | 1987 | Akush Ginekol (Mosk) | pmid:3322079 |
| Bozhinova S | [The use of the Norcolut preparation in gynecologic; practice]. | 1996 | Akush Ginekol (Sofiia) | pmid:9045566 |
| CHAMOV P et al. | [OBSERVATIONS ON THE PROGESTATIONAL ACTIVITY OF PRIMULUT N]. | 1964 | Akush Ginekol (Sofiia) | pmid:14244648 |
| Tokin R et al. | [Therapeutic potentials of treating uterine hemorrhages with norethisterone acetate]. | 1983 | Akush Ginekol (Sofiia) | pmid:6881473 |
| Rachev E | [Single-hormone prophylaxis of uterine hemorrhages in the premenopause]. | 1989 | Akush Ginekol (Sofiia) | pmid:2764256 |
| Konno A et al. | Oral contraceptives worsen endotoxin-induced liver injury in rats. | 2002 | Alcohol. Clin. Exp. Res. | pmid:12198379 |